Matsumoto, S., Ibrahim, R., Grégoire, J. C., L'Allier, P. L., Pressacco, J., Tardif, J., & Budoff, M. J. (2016). Effect of treatment with 5‐lipoxygenase inhibitor VIA‐2291 (atreleuton) on coronary plaque progression: A serial CT angiography study. Clin Cardiol.
Citação norma ChicagoMatsumoto, Suguru, Reda Ibrahim, Jean C. Grégoire, Philippe L. L'Allier, Josephine Pressacco, Jean‐Claude Tardif, and Matthew J. Budoff. "Effect of Treatment With 5‐lipoxygenase Inhibitor VIA‐2291 (atreleuton) On Coronary Plaque Progression: A Serial CT Angiography Study." Clin Cardiol 2016.
MLA引文Matsumoto, Suguru, et al. "Effect of Treatment With 5‐lipoxygenase Inhibitor VIA‐2291 (atreleuton) On Coronary Plaque Progression: A Serial CT Angiography Study." Clin Cardiol 2016.